Background: Liver regeneration is a prerequisite for extended liver surgery. Several
Introduction
Liver regeneration is regulated by a complex interaction of hepatocytes and nonparenchymal cells (figure 1). This interaction is directed by a network of cytokines, growth hormones and metabolic factors which lead to a balanced hypertrophy and hyperplasia of the liver within six months following liver resection [ synchronous liver metastasis. Some authors report a significantly increased morbidity and mortality in the case of simultaneous resection presumably caused by bacterial infections [ 9 ] .
In order to assess the effect of synbiotics in this setting, we performed an experimental study in rats. We observed that simultaneous liver and colon resection led to increased bacterial translocation and impaired liver regeneration compared to liver resection alone. Oral application of the same synbiotic combination used in the present clinical study (Synbiotic 2000) was able to reduce bacterial overgrowth and translocation and, surprisingly, also to increase the mitosis rate. ]. Therefore, the effect of synbiotics on liver regeneration is probably direct and not only via prevention of infections.
Liver regeneration is difficult to measure. We recently evaluated a new bedside test for liver function capacity which was able to predict residual liver function in 329 patients scheduled for hepatectomy [ 13 ] . The decrease of the absolute count (in µg/h/kg BW) of this LiMAx test correlates well with the loss of liver volume following resection. Therefore, it enables us to measure postoperative hepatic regeneration.
Up to now, the interaction of synbiotics and liver regeneration after resection in healthy livers has not been studied. We conducted a prospective pilot study to assess the effect of synbiotics on liver regeneration following standard hepatectomy.
Patients and Methods
The study was performed at the Department of General, Visceral and Transplantation Surgery of the University Hospital Charité, Berlin, Germany. The study protocol was approved by the local ethics committee and all patients gave their written informed consent. Between April 2007 and December 2008, 33 patients scheduled for liver resection in our department were prospectively enrolled into the study.
Inclusion criteria
Adult patients scheduled for right or extended right hemihepatectomy without bilioenteric anastomosis were eligible for this study.
Exclusion criteria
Exclusion criteria were a previous liver transplantation or porto-systemic shunt, chemotherapy within six months prior liver resection, concomitant acute infectious diseases, renal insufficiency and liver fibrosis or cirrhosis.
pectin and resistant starch, totally 10 g per dose, or 20 g per day. The treatment started on the day before operation and continued during the first 10 days after the operation.
Group B:
Identical treatment as group A, with the only difference being that the patients received only the four fibers and no probiotics (placebo group).
The sachets and its content looked identical in both groups. All persons involved in the clinical treatment of the patients were blinded for the study group.
Enteral nutrition after surgery: Oral intake started on the operation day 6 h after surgery. If the patient did not have sufficient oral intake, enteral nutrition with a lowfiber formula (Fresubin, Fresenius, Bad Homburg, Germany) was started via nasojejunal tube. The initial infusion rate was 25 ml an hour. If well tolerated, the enteral infusion rate was increased to 1ml/kg body weight/hour.
Study end point
Primary study end point was the extent of postoperative restoration of liver function measured by LiMAx-test.
In order to rule out differences in intra-and postoperative risk factors for impaired liver regeneration, the following parameters were analysed: age, preoperative body mass index (BMI) and state of health measured by American Society of Anaesthetists (ASA) -classification, operating time, number of intraoperatively transfused units of blood and plasma and incidence of surgical complications and bacterial infections. In addition, total hospital stay and side effects of the study investigational product were evaluated. Total length of hospital stay was defined as the period between day of operation and discharge.
Surveillance and definition of infection
Body temperature was measured twice daily. The diagnosis of bacterial infection was based on fever (>38°C), elevation of C-reactive protein, specific clinical symptoms of infection as shown below and a positive bacterial culture.
Pneumonia: fever, cough, dyspnea, reduced arterial oxygen, typical pulmonary infiltrate on chest x-ray, positive culture from sputum or bronchoalveolar lavage.
Cholangitis: fever, elevation of cholestatic enzymes, positive culture from T-tube.
All patients received single-shot intravenous prophylaxis with cefuroxime (1,5g) and metronidazole (500mg) 30 minutes before operation. After that, antibiotics were only given in case of bacterial infection.
Parameters of liver regeneration
To evaluate the extent of liver regeneration and its influence factors, the following parameters were measured on the day of operation and on postoperative days 1,4, 5,10 and 14:
• liver function capacity by 13 C-Methacetin-breath-test or LiMAx-test® and indocyanine green plasma disappearance rate (ICG-PDR)
• laboratory tests (haematology, clinical chemistry including ASAT, ALAT, GLDH, bilirubin, γGT, AP, PCHE, albumin and CRP, INR, factor II and VII)
• portal vein flow (duplex-sonography)
• clinical data (ascites).
13C-Methacetin-breath-test / LiMAx-test®
Methacetin is a substance exclusively metabolized by the CYP1A2 enzyme system of the liver. This enzyme system is only expressed in hepatocytes and it is proportional to the parenchymal volume of the liver. Furthermore, it is not influenced by drugs or genetic variations. The After a minimum of 6 hours fasting, the baseline 
Statistical analyis
The statistical analysis was performed using SPSS 15.0 (Chicago, Illinois, USA).
Non-parametric variables were compared by Mann-Whitney-U-test. A p-value < 0,05 was considered statistically significant.
The study was designed as a pilot study. Therefore, no sample size was calculated.
Results

Demographic and operative data
14 of the 33 enrolled patients were excluded from the study due to inoperability of the patients because of advanced tumor (n=8) and necessity of a bilio-enteric anastomosis (n=6). In total, 19 patients completed the study (group A= 9 patients, group B= 10 patients). Indications for resection were colorectal metastasis (n=10), cholangiocellular carcinoma (n=8) and hepatocellular carcinoma (n=1). Age, gender, ASA-classification, BMI and preoperative indocyanine green plasma disappearance rate were equally distributed between the two groups. However, patients in the placebo-group had a significantly higher preoperative LiMAx-test than patients in the verum group (table 1) .
Operating time was longer in the verum group. Resection type was right hemihepatectomy in 14 cases and extended right hemihepatectomy in five cases (three verum group, two placebo group). There were no significant differences regarding length of hospital stay, number of intraoperatively transfused red packed cells or fresh frozen plasma and number of postoperative complications but a trend towards a more complicated perioperative course in the verum group reflected by nearly all of these parameters (table 2).
No perioperative mortality was observed in both groups. Complications in the verum group were papillary stenosis requiring endoscopic papillotomy, bilioma, cholangitis, hepatic abscess and pneumonia (n=1 each). In the placebo group, one patient each had a hepatic abscess and cholangitis. In addition, three patients in this group had persistent high volumes of postoperative ascites requiring paracentesis.
The residual liver function measured by LiMAx-and ICG-PDR-test and the residual liver volume were comparable between the groups (table 3).
Portal vein flow and laboratory parameters
There were no significant differences regarding the portal vein flow between the two groups.
The mean values of ASAT and GLDH on postoperative day 1 were significantly higher in the verum group reflecting a greater liver damage. The ALAT peak was also more pronounced but not significant (figure 2). In parallel, gGT and bilirubin levels were higher in the verum group, but only the difference for bilirubin on postoperative day 5 was significant. The markers of liver synthesis, INR, factor II and VII, albumin and PCHE were comparable.
Regarding infection markers, the CrP on postoperative days 10 and 14 was significantly increased in the verum group whereas leucocytes were comparable.
LiMax and ICG-PDR
Liver regeneration was compared using the relative differences of LiMAx and ICG- 
Effect of complications on liver regeneration
Effect of synbiotics on liver regeneration
In order to rule out the negative effect of complications on liver regeneration and to purely analyse the effects of synbiotics, the LiMax of patients without complications was compared in the two groups. In this subgroup the relative increase of liver functional capacity measured by LiMAx on postoperative days 3 and 5 was significantly higher in the verum group (figure 5).
Side effects of enteral nutrition
The synbiotic combination was well tolerated in all patients. Mild side effects (abdominal distension and cramps) occurred in three patients of each group but disappeared under symptomatic therapy.
Discussion
Results from the present prospective, randomised, double-blind pilot study, indicate . The same probiotic combination achieved an improvement of liver function in patients with alcoholic cirrhosis [12] . In addition, the authors observed a normalisation of TNF-alpha, IL-6 and IL-10 and of markers of lipid peroxidation (Malondialdehyd, 4-Hydroxynenal and S-Nitrosothiol) which were increased at the beginning of probiotic therapy. Therefore, probiotics might act via down-regulation of endotoxin and pro-inflammatory cytokines. These cytokines are able to induce liver fibrosis and lipid peroxidation which is a trigger for the development of steatohepatitis. TNF-alpha and IL-6 are also involved in the process of liver regeneration (figure 1). One might speculate that probiotics also have an influence in this setting. However, the authors did not assess liver regeneration directly. This might be based on the fact, that measurement of liver function and liver regeneration after hepatic surgery is difficult. This problem has been overcome in the present study, using the newly developed LiMAx test. This test is a reliable tool for the determination of liver functional capacity [14] and thereby a surrogate parameter for liver regeneration.
Liu et al showed that cirrhotic patients who received oral synbiotics (Synbiotic 2000) had a significant improvement of minimal hepatic encephalopathy and the Child Pugh score compared to the control group [ 18 ].
In the present study, only patients with healthy livers lacking severe parenchymal damage scheduled for a right hepatectomy with low risk for hepatic failure were included in order to focus on liver function and to increase the homogenity of the study groups. The LiMax test was chosen because this test has been shown to be very accurate and easy to perform in previous studies and in clinical practice [13] . In addition, an ICG-PDR was performed in each patient as a control test. Both tests showed similar results.
As expected, patients with postoperative complications had significant impairment of liver function. Comparison of mean LiMAx and ICG-PDR values between the whole verum and placebo group did not show any differences. This fact might be explained by a higher incidence of severe surgical complications in the verum group. In addition, patients in the verum group had higher levels of ASAT, GLDH, bilirubin and CrP immediately following operation thus reflecting a greater liver damage.
The study was planned as a pilot study. Therefore, patient numbers are too small and the type of complications too diverse to analyse all subgroups separately. Further studies with more patients are needed to confirm these results. In this case, synbiotics could be very useful especially in patients with extended hepatectomies. 
